Your browser doesn't support javascript.
loading
Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.
Õunpuu, Sylvia; Pierz, Kristan A; Acsadi, Gyula; Wren, Tishya A L.
  • Õunpuu S; Center for Motion Analysis, Connecticut Children's Medical Center, 399 Farmington Ave. Farmington, CT, USA. Electronic address: sounpuu@connecticutchildrens.org.
  • Pierz KA; Center for Motion Analysis, Connecticut Children's Medical Center, 399 Farmington Ave. Farmington, CT, USA; Division of Orthopedics, Connecticut Children's Medical Center, 399 Farmington Ave. Farmington, CT, USA.
  • Acsadi G; Division of Neurology, Connecticut Children's Medical Center, 505 Farmington Ave. Farmington, CT, USA.
  • Wren TAL; Children's Orthopedic Center, Children's Hospital Los Angeles, 4650 Sunset Bvld, Los Angeles, CA, USA.
Neuromuscul Disord ; 30(10): 825-832, 2020 10.
Article en En | MEDLINE | ID: mdl-32928646
ABSTRACT
The purpose of this study is to assess how Charcot-Marie-Tooth disease, a group of inherited peripheral neuropathies that result in distal weakness, affects walking velocity over time in comparison to age-matched controls. Comprehensive gait analysis of 57 children (mean age 12.0, SD 3.7 years) compared to 76 age-matched controls (mean age 10.1, SD 3.4 years) demonstrated slower walking velocity (p<0.001) due to both shorter stride length (p<0.001) and diminished cadence (p=0.01). There was higher walking velocity (p<0.001), stride length (p=0.002) and cadence (p<0.001) in patients with dorsiflexor strength ≥3 and higher walking velocity (p=0.001) and cadence (p=0.03) in patients plantar flexor strength ≥4. Analysis of Charcot-Marie-Tooth type 1 and type 2 subgroups showed that walking velocity increased significantly with age in controls (p=0.001) but did not increase in children with either subtype (p>0.54). Stride length increased significantly with age in all groups (p<0.001) but at a slower rate in type 1 and 2 compared to controls. These differences contributed to increasing deficits in walking velocity and stride length with age in type 1 and 2 in comparison to controls, with deficits appearing earlier in type 2. Since the slower walking velocity in children with Charcot-Marie-Tooth disease is primarily due to short stride length, treatments that enable improved stride length, such as plantar flexor strengthening and bracing, may improve walking velocity and associated gait function.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Charcot-Marie-Tooth / Trastornos Neurológicos de la Marcha / Fuerza Muscular / Pie / Velocidad al Caminar Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Charcot-Marie-Tooth / Trastornos Neurológicos de la Marcha / Fuerza Muscular / Pie / Velocidad al Caminar Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article